Retatrutide is a novel therapeutic/treatment/medicine agent under investigation for the management/treatment/control of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists/glucagon-like peptide-1 receptor agonists/glucose-dependent insulinotropic polypeptide agonists, which work by stimulating/activating/enhancing the r… Read More

Arriving in the arena of obesity therapy, retatrutide is a unique approach. Unlike many existing medications, retatrutide works as a double agonist, at once affecting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) binding sites. This simultaneous activation encourages several helpful effects, like improved gluc… Read More